ArticleEndocrinology, diabetes & metabolism case reports2021

The use of SGLT2 inhibitors in achieving glycaemic control in maturity-onset diabetes of the young type 3.

Arunan Sriravindrarajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.